Maria Werner‐Wasik

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Randomized phase II study of rituximab, methotrexate (MTX), procarbazine, vincristine, and cytarabine (R-MPV-A) with and without low-dose whole-brain radiotherapy (LD-WBRT) for newly diagnosed primary CNS lymphoma (PCNSL).”.

Randomized phase II study of rituximab, methotrexate (MTX), procarbazine, vincristine, and cytarabine (R-MPV-A) with and without low-dose whole-brain radiotherapy (LD-WBRT) for newly diagnosed primary CNS lymphoma (PCNSL).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.2501

N/A

0DataRank · unranked

59 citations

Lisa M. DeAngelis, Theodore Karrison, Joe A Bovi, Marc K. Rosenblum, Benjamin W. Corn +16 more

Long-term analysis of the WHO-defined molecular subgroups of high-risk grade II gliomas treated with radiation and temozolomide on NRG Oncology/RTOG 0424.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.2518

N/A

0DataRank · unranked

1 citations

Stephanie L. Pugh, Barbara J. Fisher, Glenn J. Lesser, David R. Macdonald, Jessica L. Fleming +15 more

Characterizing Pulmonary Function Test Changes for Patients With Lung Cancer Treated on a 2-Institution, 4-Dimensional Computed Tomography-Ventilation Functional Avoidance Prospective Clinical Trial

Advances in Radiation Oncology(2022)10.1016/j.adro.2022.101133

N/A

0DataRank · unranked

17 citations

Richard Castillo, Edward Castillo, Bernard L. Jones, Moyed Miften, Brian D. Kavanagh +10 more

Safety results of NRG-LU004: Phase I trial of accelerated or conventionally fractionated radiotherapy combined with durvalumab in PD-L1–high locally advanced non-small cell lung cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.8513

N/A

0DataRank · unranked

19 citations

Stephanie L. Pugh, Anne S. Tsao, Martin Joseph Edelman, Anthony Doemer, Charles B. Simone +12 more

Consensus Quality Measures and Dose Constraints for Lung Cancer From the Veterans Affairs Radiation Oncology Quality Surveillance Program and ASTRO Expert Panel

Practical Radiation Oncology(2023)10.1016/j.prro.2023.04.003

N/A

0DataRank · unranked

16 citations

Mohammad Titi, Ksenija Kujundzic, Samantha Dawes, Elizabeth Gore, Evangelia Katsoulakis +16 more

Evaluation of variables predicting PFT changes for lung cancer patients treated on a prospective 4DCT-ventilation functional avoidance clinical trial

Radiotherapy and Oncology(2023)10.1016/j.radonc.2023.109821

N/A

0DataRank · unranked

2 citations

Richard Castillo, Edward Castillo, Bernard L. Jones, Moyed Miften, Brian D. Kavanagh +9 more

Novel Functional Radiomics for Prediction of Cardiac Positron Emission Tomography Avidity in Lung Cancer Radiotherapy

JCO Clinical Cancer Informatics(2024)10.1200/cci.23.00241

N/A

0DataRank · unranked

4 citations

Yingcui Jia, Jennifer Kwak, Maria Werner‐Wasik, Adam P. Dicker, Nicole L. Simone +4 more